ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

Did you buy ADMA securities between August 9, 2024 and March 25, 2026? Affected ADMA Investor Summary Who: ADMA Biologics, Inc. (NASDAQ: ADMA) What: Securities fraud class action lawsuit filed Class Period: August 9, 2024 through March 25, 2026 Deadline to Seek Lead Plaintiff Status:...